Pharmaron · 10 hours ago
Scientist, Kilo Lab Coventry
Pharmaron is a premier service provider for the life sciences industry, and they are seeking a Senior Scientist to join their manufacturing site in Coventry, RI. The Senior Scientist, Analytical will support manufacturing and process chemistry activities through analytical method development, optimization, validation, and transfer.
BiotechnologyChemicalPharmaceutical
Responsibilities
Review and Approval of Scientific Reports and SOPs
Overseeing leadership on several analytical project teams working to tight deadlines
Planning teamwork and prioritizing as necessary with minimal supervision
Implementing new analytical techniques and strategies to expand departmental capabilities
Solving multiple complex scientific problems
Ensuring adherence to GMP
Presenting and communicating clearly and effectively with clients
Qualification
Required
PhD in Analytical Chemistry with 5 years of experience or MSc in Analytical Chemistry or related field with 10 years of experience with the following instrumentation: HPLC, GC, FTIR, UV, LC/MS
Excellent communication skills, both verbal and written
Effective in managing multiple competing activities and delivering to timelines
Ability to work in a cross-functional environment
High level of awareness of innovative technologies and ability to adapt to in-house needs
Preferred
Working knowledge of cGLP/cGMP and applicable FDA, EMA, and ICH guidance
Benefits
Medical, Dental & Vision Insurance with significant employer contributions.
Employer-funded Health Reimbursement Account.
Healthcare & Dependent Care Flexible Spending Accounts.
100% Employer-paid Employee Life and AD&D Insurance.
Short- and Long-Term Disability Insurance.
401(k) plan with generous employer match.
Access to an Employee Assistance Program.
Company
Pharmaron
Pharmaron is a contract research organization that offers research and development services for the life science industries.
Funding
Current Stage
Public CompanyTotal Funding
$907.82MKey Investors
GL Capital
2019-11-22Post Ipo Equity· $587.82M
2019-01-28IPO
2015-12-14Series Unknown· $280M
Recent News
2026-01-16
Precedence Research
2025-11-07
Business Wire
2025-10-29
Company data provided by crunchbase